Telomir Pharmaceuticals, Inc. (TELO)
NASDAQ: TELO · Real-Time Price · USD
2.150
+0.140 (6.97%)
At close: Jun 6, 2025, 4:00 PM
2.160
+0.010 (0.47%)
After-hours: Jun 6, 2025, 6:26 PM EDT
Telomir Pharmaceuticals Market Cap
Telomir Pharmaceuticals has a market cap or net worth of $63.39 million as of June 6, 2025. Its market cap has decreased by -64.55% in one year.
Market Cap
63.39M
Enterprise Value
61.60M
1-Year Change
-64.55%
Ranking
Category
Stock Price
$2.15
Market Cap Chart
Since the IPO on February 9, 2024, Telomir Pharmaceuticals's market cap has decreased from $207.27M to $63.39M, a decrease of -69.41%. That is a compound annual growth rate of -59.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2025 | 59.82M | -51.20% |
| Dec 31, 2024 | 122.58M | -40.86% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 689.12B |
| Johnson & Johnson | 370.27B |
| AbbVie | 333.74B |
| Novo Nordisk | 315.80B |
| UnitedHealth Group | 274.70B |
| Abbott Laboratories | 233.64B |
| Novartis AG | 226.74B |
| AstraZeneca | 223.00B |